PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-29

Date Title Company
29-Jan-2026 The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age Bracco Imaging S.p.A.
29-Jan-2026 Augmented Reality (AR) and Virtual Reality (VR) in Healthcare Market Growth, Opportunities, Sales, Trends service, applications and forecast 2029 Medi-Tech Insights
29-Jan-2026 Hampshire Hospitals NHS Foundation Trust boosts imaging productivity and resilience following major CT upgrade Canon Medical Systems
29-Jan-2026 Alzheimer’s Drugs Market Growth, Opportunities, Sales, Trends service, applications and forecast 2029 Medi-Tech Insights
29-Jan-2026 Amniotic Products Market 2031 | Size, Share, Analysis, Growth by Segmentation and Forecast Medi-Tech Insights
29-Jan-2026 Interventional Radiology Market by Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2030 Medi-Tech Insights
29-Jan-2026 ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing ViCentra
29-Jan-2026 Biocomposites launches SYNICEM™ spacers in Canada Biocomposites
29-Jan-2026 TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development TECregen
29-Jan-2026 Disposable Endoscopes Market 2030 | Size, Share, Trends and Research Report Forecast Medi-Tech Insights
29-Jan-2026 ScribeRyte ClickNote Seamlessly Flows ScribeRyte
29-Jan-2026 Poolbeg Pharma plc - Peer-Reviewed POLB 001 LPS Challenge Trial Paper Published in Frontiers in Immunology Poolbeg Pharma plc
29-Jan-2026 NHSBSA analysis estimates patients could have spent over £880 million on prescription costs without a PPC NHSBSA
29-Jan-2026 En Carta Diagnostics receives FDA Breakthrough Device Designation for EC Pocket Lyme test En Carta Diagnostics
29-Jan-2026 Ondine continues to expand its Steriwave treatment to reduce surgical site infections in hospitals across Canada Ondine
29-Jan-2026 Four additional sites open for recruitment in Oncoinvent’s Phase 2 trial Oncoinvent
29-Jan-2026 ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections ENA Respiratory
29-Jan-2026 ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections ENA Respiratory
29-Jan-2026 Global Metabolic Disorder Therapeutics Market Set for Robust Expansion Through 2036, Says FutureWise Research Futurewise Research
29-Jan-2026 Yunu Extends from Site Imaging Standard to Central Review Workflow Leader ACCESS Newswire